Clinical Trial Update: Post-surgical Scars After the Use of CACIPLIQ20 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on CACIPLIQ20 for post-surgical scars is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scars

Drugs mentioned

• CACIPLIQ20

Snippet

Sponsor: Organ, Tissue, Regeneration, Repair and Replacement | Conditions: Scars | Phase 3 | Status: UNKNOWN